MPM 1g Injection (Meropenem) | Pharma Services Group

MPM 1g Injection contains Meropenem 1g, a broad-spectrum carbapenem antibiotic used for the treatment of serious bacterial infections. It is supplied as an intravenous (IV) powder for injection and is intended for administration by a qualified healthcare professional. The attached packaging identifies MPM as Meropenem 1g Injection (USP Specs) and shows a pack containing 1 vial + 20mL sterile water for injection (diluent). Athix's product portfolio confirms MPM 1g as a Meropenem product.

Meropenem 1g injection is a prescription antibiotic commonly used in hospital settings for serious infections caused by susceptible bacteria, including certain complicated intra-abdominal infections, severe skin and skin-structure infections, bacterial meningitis, and other serious infections as determined by a physician. Because Meropenem is a powerful prescription antibiotic, it should only be used when clinically indicated and according to an appropriate antimicrobial treatment plan.

Key Benefits

\n
• Contains Meropenem 1g.
\n
• Broad-spectrum carbapenem antibiotic.
\n
• Used for serious bacterial infections caused by susceptible microorganisms.
\n
• Intended for intravenous (IV) administration.
\n
• Supplied with 20mL sterile water for injection (diluent) as shown on the product packaging.
\n
• Appropriate for hospital and clinical use under professional medical supervision.
\n

How It Works

Meropenem works by interfering with bacterial cell wall synthesis. It binds to bacterial penicillin-binding proteins and prevents the formation of a stable bacterial cell wall, ultimately leading to bacterial cell death. Its broad antibacterial activity makes it useful against a wide range of susceptible Gram-positive and Gram-negative bacteria.

Directions for Use

MPM 1g Injection should be prepared and administered by a doctor, nurse, pharmacist, or other qualified healthcare professional. The dose, frequency and duration of treatment depend on the type and severity of infection, the patient's age, body weight, kidney function and the susceptibility of the causative bacteria.

The injection is administered intravenously after appropriate reconstitution and dilution according to professional prescribing and preparation instructions. Do not self-inject or attempt to prepare this medicine without professional training.

Precautions

\n
• Use only on the advice and prescription of a qualified healthcare professional.
\n
• Tell your doctor if you have previously experienced an allergic reaction to Meropenem, other carbapenems, penicillins or cephalosporin antibiotics.
\n
• Inform your doctor if you have kidney disease, as dosage adjustment may be necessary.
\n
• Tell your healthcare professional about all medicines you are taking.
\n
• Particular caution may be required in patients receiving valproic acid or valproate, as Meropenem can significantly reduce valproate concentrations.
\n
• Antibiotics should be used only for appropriate bacterial infections and should not be used for viral infections such as common colds or influenza.
\n
• Complete the prescribed treatment course unless your healthcare professional advises otherwise.
\n

Possible Side Effects

Possible adverse effects of Meropenem may include diarrhea, nausea, vomiting, headache, rash, injection-site reactions and inflammation of the injection site. Serious allergic reactions, seizures or severe antibiotic-associated diarrhea can occur in some patients and require prompt medical attention.

Storage Instructions

\n
• Store according to the manufacturer's recommended conditions.
\n
• Keep the unopened vial in its original packaging.
\n
• Protect from excessive heat, moisture and direct sunlight.
\n
• Keep out of reach of children.
\n
• Reconstituted or diluted solutions should be handled and stored according to the approved product information and healthcare facility procedures.
\n

Manufacturer Information

Brand: MPM \nGeneric Name: Meropenem \nStrength: 1g \nManufacturer/Company: Athix Pvt. Ltd., Pakistan \nDosage Form: Injection \nRoute: Intravenous (IV)

Athix's official product information lists MPM 1G under its domestic operations with Meropenem as the composition and confirms MPM as part of its pharmaceutical portfolio.

Product Specifications